Kezar Life Sciences, Inc. (KZR) delivered a return of 52.19% over the past year. Since KZR does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Kezar Life Sciences, Inc. one year ago would be worth $15,219 today, representing a gain of $5,219.

Kezar Life Sciences, Inc. (KZR) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For KZR, the total return equals the price-only return.

Yes, Kezar Life Sciences, Inc. (KZR) outperformed the S&P 500 by 29.34 percentage points over the past year. KZR delivered a total return of 52.19%, compared to the S&P 500's 22.86%. This 29.34pp alpha means investors in KZR earned more than a passive S&P 500 index fund.

Kezar Life Sciences, Inc. (KZR) experienced a maximum drawdown of -25.05% over the past year, declining from its peak on 2025-07-10 to its trough on 2025-09-29. The stock recovered to its prior peak by 2025-10-17. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Kezar Life Sciences, Inc. (KZR)'s long-term returns with dividends reinvested. Over 10 years, the total return is -99.6% (-42.3% CAGR) — $10,000 would have grown to $41. Over 20 years: -99.6% total return (-24.0% CAGR) — $10,000 → $41. Over 30 years: -99.6% total return (-16.7% CAGR) — $10,000 → $41. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Kezar Life Sciences, Inc.'s best calendar year was 2021 with a total return of 216.7%. Its worst year was 2024 with a total return of -92.9%. This range shows the volatility investors should expect — the difference between the best and worst year is 309.6 percentage points.